VRSK CFO Sells $72.7k in Stock via Pre-Arranged Trading Plan
Verisk Analytics, Inc.
Subscribe to track VRSK
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
VRSK CFO Sells $72.7k in Stock via Pre-Arranged Trading Plan
Company: Verisk Analytics, Inc. (VRSK) Form: 4 | Filed: 2025-10-15 Significance: Low
Insider: Elizabeth Mann Title: Chief Financial Officer | Relationship: Officer
Transaction: • Type: Sell • Shares: 300 • Price: $242.23 • Value: $72,669 • Owned After: 14,865
Key Insight: This sale was executed under a pre-scheduled 10b5-1 trading plan, indicating it was planned in advance and is not necessarily a reaction to recent company events.
Market Context: Pre-arranged sales by executives are common for financial planning and diversification and are generally considered neutral market signals.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: Verisk Analytics, Inc. (VRSK)
Executive Summary
- Trading Significance: Low
- Key Takeaway: The Chief Financial Officer of Verisk Analytics, Inc. sold 300 shares for a total of $72,669. The transaction was conducted under a pre-established 10b5-1 trading plan, which significantly diminishes its importance as a market signal.
- Market Impact: The impact is expected to be neutral. Sales under 10b5-1 plans are pre-scheduled and do not typically reflect an insider's current sentiment about the company's short-term prospects.
Company Information
| Field | Value |
|---|---|
| Company | Verisk Analytics, Inc. |
| Ticker Symbol | VRSK |
| CIK | 0001442145 |
| Industry | SERVICES-COMPUTER PROCESSING & DATA PREPARATION |
Insider Information
| Field | Value |
|---|---|
| Name | Elizabeth Mann |
| CIK | 0001946842 |
| Title/Position | Chief Financial Officer |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-10-15 |
| Transaction Code | S (Open market or private sale of securities) |
| Security Type | Common Stock |
| Shares Involved | 300 |
| Price Per Share | $242.23 |
| Total Value | $72,669.00 |
| Shares Owned After | 14,865 |
| Ownership Type | Direct |
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The sale is of a relatively small value for a C-suite executive. More importantly, it was executed pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2024. This indicates the trade was planned months in advance for reasons likely related to personal financial management, such as diversification or tax planning, rather than a bearish outlook on the company.
Volume & Sentiment
- Expected Volume Impact: Negligible. A 300-share transaction will not materially affect the trading volume of VRSK.
- Sentiment Indicator: Neutral. The market generally discounts the significance of sales made under 10b5-1 plans.
Investment Insights
Positive Market Indicators
- The insider still holds a significant position of 14,865 shares after the sale, indicating continued alignment with shareholder interests.
Risk Factors
- While this specific transaction is not a concern, investors should monitor the frequency and size of future sales by insiders, even under 10b5-1 plans.
Key Takeaways
- Planned Disposition: This is a routine, pre-planned sale, not an opportunistic trade based on non-public information.
- Low Monetary Value: The total value of ~$72.7k is not substantial enough to signal a major change in the insider's conviction.
- Continued Ownership: The CFO maintains a sizable stake in the company post-transaction.
Contextual Analysis
Timing Significance
The transaction date coincides with the filing date, indicating prompt reporting. The key timing element is that the plan was established nearly a year prior to the sale, detaching the decision to sell from the market conditions on the day of the transaction.
Transaction Context
The filing explicitly states in a footnote that "These shares were sold pursuant to a 10b5-1 plan that Ms. Mann entered into on December 13, 2024." This provides a clear and non-controversial context for the sale.
Company Context
An analysis of this filing should be paired with a review of Verisk's recent performance, earnings reports, and any major announcements around the transaction date to ensure no other material events coincide with the sale, though the 10b5-1 plan makes this less critical.
Risk Assessment
Risk Level: Low
Risk Factors
- Misinterpretation: The primary risk is that uninformed market participants might misinterpret this as a bearish signal without understanding the context of the 10b5-1 plan.
- Signal Aggregation: If this sale is part of a larger pattern of dispositions by multiple insiders, it could collectively be viewed more negatively.
Market Considerations
- Routine Executive Liquidity: C-suite executives often have automated, planned selling programs to diversify their wealth, which is heavily concentrated in company stock.
- Market Perception: Sophisticated investors and algorithms typically filter out or assign low weight to 10b5-1 plan transactions.
IMPORTANT DISCLAIMER: This analysis is for informational purposes only and is not intended as investment advice. The information presented is based on publicly available SEC filings and should not be construed as a recommendation to buy, sell, or hold any securities. Past performance does not guarantee future results. All investments carry risk, including the potential loss of principal. Please consult with a qualified financial advisor before making any investment decisions.
Analysis generated on 2025-10-15 | Data source: SEC EDGAR
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
